Doctor profile · Federal record
Dr. JACOB LEVITT, M.D.
Dermatology Physician (CMS: DERMATOLOGY) · NEW YORK, NY
- NPI 1568457679
- Accepts Medicare
- 26 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
5 E 98TH ST FL 5, BOX 1048
NEW YORK, NY 100296501
(212) 241-9728
fax (212) 987-1197
Credentials & registration
- NPI registered
- September 2005 — 21 yrs on file
- Profile last updated
- July 11, 2007
- Year of graduation
- 2000 — 26 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- New York #222218
- Medicaid
- NY #02584958
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1568457679. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
320
Distinct HCPCS
10
Medicare allowed
$38,863
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 105 | 63 | $148 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 70 | 48 | $105 | |
11102 |
Biopsy of related skin growth, first growth | 23 | 21 | $111 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 23 | 23 | $193 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 22 | 22 | $131 | |
36415 |
Insertion of needle into vein for collection of blood sample | 20 | 16 | $8 | |
17000 |
Destruction of precancer skin growth, 1 growth | 16 | 12 | $72 | |
11104 |
Punch biopsy, first skin growth | 14 | 14 | $151 | |
17110 |
Destruction of skin growth, 1-14 growths | 14 | 11 | $136 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 13 | 12 | $64 |
In context: peer comparison
Among 139 peers in this city , average services per provider: 182. This provider delivers 1.8× the peer median.Open Payments
Industry payments received
All-time total
$2,901
Transactions
128
Manufacturers
14
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 26 | $684.72 | |
| Dermavant Sciences, Inc. | 38 | $495.25 | |
| Lilly USA, LLC | 16 | $336.83 | |
| UCB, Inc. | 5 | $264.09 | |
| PFIZER INC. | 7 | $232.57 | |
| Incyte Corporation | 2 | $228.81 | |
| Janssen Biotech, Inc. | 7 | $158.41 | |
| E.R. Squibb & Sons, L.L.C. | 13 | $143.74 | |
| Regeneron Healthcare Solutions, Inc. | 3 | $95.28 | |
| Galderma Laboratories, L.P. | 4 | $81.59 | |
| Arcutis Biotherapeutics, Inc. | 3 | $70.95 | |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $49.07 | |
| GENZYME CORPORATION | 1 | $30.46 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28.80 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
450
Patients
101
Total drug cost
$730,891
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Opzelura (Ruxolitinib Phosphate) | Brand | 77 | 24 | $188,981 |
| Dupixent Pen (Dupilumab) | Brand | 55 | 0 | $214,263 |
| Tacrolimus | Generic | 45 | 17 | $13,169 |
| Gabapentin | Generic | 36 | 0 | $661 |
| Prednisone | Generic | 36 | 14 | $296 |
| Doxycycline Hyclate | Generic | 27 | 12 | $880 |
| Clobetasol Propionate | Generic | 23 | 18 | $2,026 |
| Vtama (Tapinarof) | Brand | 23 | 0 | $34,710 |
| Mupirocin | Generic | 22 | 16 | $172 |
| Tretinoin | Generic | 22 | 0 | $4,087 |